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Abstract
Background: Endometrial remodelling is necessary for implantation in all mammalian species. The TGF beta super-
family plays a crucial role in this event in humans and mice. However, the role of TGF beta super-family members
during implantation is still unclear in ruminants. In the present study, the spacio-temporal expression of TGF beta
super-family members including activin was explored in bovine trophoblasts and endometrial tissue during the
peri-implantation period in order to elucidate whether it is essential for promoting cell proliferation at the
implantation site.
Methods: Gene expression in the fetal membrane and endometrium of the gravid and non-gravid horn around
Day 35 of gestation were analyzed with a custom-made oligo-microarray in cattle. The expression of activin and its
related genes was also analyzed with quantitative RT-PCR. Activin-like activity in trophoblastic tissue and BT-1 cells
was examined using a fibroblast cell proliferation test and Western blotting.
Results: The expression of various TGF beta super-family related genes including activin was detected in
trophoblasts and the endometrium in cattle. The most intensive activin expression was found in the gravid horn
endometrium, and rather intense expression was detected in the non-gravid trophoblastic tissue. Extracts from the
fetal membrane including trophoblasts and purified activin both stimulated fibroblast proliferation effectively, and
activin was immunologically detected in BT-1 cells, which have trophoblastic features.
Conclusions: Specific expression of the activin gene (gene name: inhibin beta A) was found in the gravid horn
endometrium during peri-implantation. An activin-like molecule, which was derived from the endometrium and
trophoblasts, stimulated the proliferation of fibroblast cells. These results suggested that as in other species, the
activity of TGF beta super-family members including activin-like molecules plays a pivotal role in endometrial
remodelling, which is an essential process in implantation and placentogenesis during the peri-implantation period
in cattle.
Background
Implantation involves a complex process and various
kinds of factors, during which time the fetal-maternal
interface develops into the placenta. Trophoblast cells
and maternal endometrial cells adhere to each other and
produce the feto-maternal interface, which represents
the beginning of implantation and endometrial remodel-
ling. However, the cells from the fetus and mother only
fuse and develop into the placentome in a limited area,
namely the caruncle (CAR) on the endometrium in
cattle [1]. Stromal cells proliferate in the CAR during
peri-implantation, which corresponds to the proliferative
activity of trophoblasts. In cattle, the rapid proliferation
and differentiation of the early embryo and/or the con-
ceptus begins in the gravid horn, which contains the
fetus, and the conceptus grows with morphological
changes such as the development of spherical, ovoid,
filamentous, and elongated membranes, the latter of
which then spreads to the other side of the uterine horn
(non-gravid horn) [2-5]. In particular, endometrial and
fetal trophoblastic cells markedly proliferate at the CAR,
where the placentome develops as the feto-maternal
interface including the epithelium and stroma. Various
molecules derived from trophoblastic and endometrial
cells including cytokines, growth factors, and hormones
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the fusion of trophoblast and endometrial epithelial cells
starts around 20 days of gestation [7-9]. Although these
phenomena have been morphologically confirmed, the
detailed mechanisms behind them are still unclear in
ruminants. Various growth factors, such as heparin-
binding epidermal growth factor (HB-EGF) and trans-
forming growth factors (TGFs), promote crucial events
during the peri-implantation period in humans and
mice [10-14]. These growth factors may affect the initia-
tion of endometrial proliferation during implantation in
these species.
TGFb superfamily members including activin and
some growth factors participate in this critical event in
mice and humans [15-17] but little information is avail-
able about this process in ruminants. A microarray
study suggested that activin (gene name: inhibin bA)
coordinates endometrial remodelling in cattle [18]. In
other species, there is evidence that activin is involved
in endometrial remodelling [15]. Activin, which was ori-
ginally identified as a peptide growth factor obtained
from the ovarian follicular fluid [19], is a disulphide-
linked dimeric glycoprotein composed of two subunits
in various combinations, bAa n dbA (homodimer), bA
and bB (heterodimer), and bBa n dbB( h o m o d i m e r ) ,
which were named activin A (gene symbol: INHbA),
activin AB (INHbAB), and activin B (INHbB), respec-
tively. Both the bAa n dbB subunits can also be com-
bined with the a-subunit to form inhibin-A (abA) and
-B (abB), respectively [20]. Follistatin, which is related
to activin and inhibin, and can be purified from ovarian
follicular fluid, binds to activin with high affinity and
neutralizes activin bioactivity [21]. Although the TGFb
super-family members regulate the cell proliferation in
various kinds of cells via complex mechanisms, they
may stimulate endometrial cell activity and function
[22,23]. In humans, activin plays a stimulatory role in
decidualization and endometrial cell invasion [12,24,25].
T h ea i m so ft h i ss t u d ya r et oc o n f i r mt h ee x p r e s s i o n
of TGFb super-family members during gestation, and to
explore the factors that promote cell proliferation at the
implantation site and the possible role of activin, which
is a TGFb super-family member, in trophoblasts and the
endometrium during the peri-implantation period.
Methods
Tissue Preparation
The following tissues were used to obtain total RNA
from Japanese Black cows: the fetal membrane (FM) and
endometrium (END) of the gravid horn (GH) and/or the
non-gravid horn (NGH) were collected separately. Some
tissues such as the FM were only collected for microar-
ray analysis, in which it was difficult to identify the coty-
ledonary (COT) and intercotyledonary (ICOT) sections
during the early period of implantation. After day 50 of
gestation COT, ICOT, caruncular (CAR) and intercar-
unclar (ICAR) endometrium were separately collected.
Endometrial tissues for gene expression analysis were
collected from cows on day 7-14 of the estrous cycle
( n=3 ) .T h em a i nt i s s u ec o l l ection schedules are sum-
marized in Table 1. The day of artificial insemination
was designated as Day 0 of gestation. All tissues used
for the gene, biological, and biochemical analyses were
snap frozen in liquid nitrogen and stored at -80°C until
RNA and protein extraction. All animal experiments
and procedures were approved by the Animal Experi-
mental Committee of Iwate University and National
Institute of Agrobiological Sciences.
Bovine endometrial (E cells) or cotyledonary (C cells)
fibroblast cells were derived from the endometrium and
cotyledon, respectively, of Japanese Black cattle that
were reared at the National Institute of Agrobiological
Sciences [26,27] and used for the proliferation assay. In
brief, small pieces of tissue were subjected to explant
culture, and the cells that grew around the explanted
tissue were collected and passaged at least three times
to generate a fibroblast cell population, and then less
than 10 passaged cells were used as fibroblast cells after
immunohistochemical characterization with vimentin
and cytokeratin, as described previously [27]. C cell was
c o n f i r m e da sac e l ld e r i v e df r o mc o t y l e d o n a r yt i s s u ea s
shown in Figure 1 using Y-chromosome specific gene
[28]. The bovine trophoblast cell line (BT-1), which was
established in our laboratory [29], and bovine skin fibro-
blasts (SKIN) were prepared and used as a control in
the total RNA expression and protein extraction ana-
lyses. Primary bovine SKIN cells were established from
dermis tissue derived from the bovine shoulder. After all
hair had been removed and the tissue had been rinsed
in 70% ethanol, the tissue was washed in phosphate
Table 1 Tissue collection schedule for gene expression
analysis
Cyclic GH NGH GH NGH
a: For microarray and quantitative RT -PCR (number of animals)
Day of gestation END FM FM END END
35-37* 3 3 2 3 3
b: For quantitative RT-PCR (number of animals)
Day of gestation FM COT ICOT CAR ICAR
27-34 6 - - 5 5
48-64 2 5 8 9
93-150 4 6 7 9
240-270 3 4 5 7
GH: gravid horn, NGH: non-gravid horn, FM: fetal membrane, END:
endometrium, COT: cotyledonary fetal membrane, ICOT: intercotyledonary
fetal membrane, CAR: caruncular tissue of the endometrium, ICAR:
intercaruncular tissue of the endometrium. *:Data was shown in text and
tables as Day 35.
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and 100 μg/mL of streptomycin several times. It was
then minced thoroughly with scissors and placed on
plastic Petri dishes, before being carefully filled with
DMEM/F-12 medium supplemented with 10% FBS.
These cells were then cultured in Dulbecco’s modified
Eagle’s medium/F-12 medium (DMEM/F-12, Sigma,
Saint Louis, MI, USA) containing 100 IU/mL of penicil-
lin and 100 μg/mL of streptomycin (Sigma), supplemen-
ted with 10% fetal bovine serum (FBS, HANA-NESCO,
Tokyo, Japan), at 37°C in an atmosphere of 5% CO2.
The confluent fibroblast cells were scale passaged using
0.25% trypsin-EDTA (Sigma) and plated on flasks. The
BT-1 cells were cultured according to the previously
described method [30].
Protein extraction and purification
Frozen FM (Day 90 of gestation) was thawed in chilled
PBS (containing penicillin and streptomycin) before
being minced. After five minutes of PBS supplementa-
tion, they were centrifuged at 300 ×g for 10 minutes at
4°C, and the supernatant was removed. These steps
were repeated until all blood cell factors had been
removed from the supernatant. Following the addition
of PBS, the minced tissues were homogenized using a
polytron homogenizer (ULTRA TURRAX T25, IKA
Works, NC, USA) and centrifuged at 44,000 ×g for 10
minutes at 4°C. The supernatant was then stored at
-30°C until the proliferation assay.
The protein extraction from SKIN and BT-1 cells was
performed using the following procedures: the SKIN
cells were washed twice with serum-free medium
(DMEM/F12) in close to confluent conditions and then
incubated with medium (serum-free) at 37°C for two
hours. After being washed twice, the cells were scraped
using a cell scraper in PBS, and the resultant cell sus-
pension was centrifuged at 1,000 ×g for 10 minutes at
room temperature. The pellet was then re-suspended in
two volumes of PBS, before being homogenized and
centrifuged as in the FM procedure. The supernatant
was used for protein analysis. The BT-1 cells were
washed three times with serum-free medium and incu-
bated in serum-free medium at 37°C for two hours to
eliminate contaminating factors from the FBS. Then, all
cells were cultured in 2 mL of serum-free medium for
48 h, collected, and used for protein analysis. The condi-
tioned medium was collected after centrifugation at
3,000 ×g for 10 minutes. The pellet was then homoge-
nized, and the supernatant was collected as mentioned
for the SKIN cell procedure. To concentrate the condi-
tioned medium, 2 mL of medium were mixed with 8
mL of cold acetone. After being incubated overnight at
-30°C, the sample was centrifuged at 10,000 ×g for 10
minutes, and the pellet was suspended in 100 μL of PBS
and used for further analysis.
An activin-like substance was extracted from the BT-1
cells using sulfated Cellulofine (Seikagaku biobusiness,
Tokyo, Japan), which is an affinity chromatography
reagent that concentrates TGFb related molecules [31],
according to the manufacturer’s instructions. In brief,
after the Cellulofine extract had been washed five times
with PBS, 100 μg of BT-1 extract and 100 μL of Cellulo-
fine were mixed and incubated for 2 hours at 4°C on the
rotator. The mixtures were then washed three times
with PBS, and 50 μg of PBS with 1 M NaCl were added.
After 1 h incubation at 4°C, they were centrifuged at
10,000 ×g for 5 min at 4°C, and the supernatants were
collected.
Proliferation assay
The E and C cells were plated at 1 × 10
5 cells/dish and
incubated in DMEM/F12 medium containing 10% FBS
a t3 7 ° Ci na na t m o s p h e r eo f5 %C O 2. The cells were
then washed twice with PBS and incubated in DMEM/
F12 medium without FBS for 24 h at 37°C. The cells
extracts (protein concentrations ranging from 1~100 μg/
mL) and growth factors (as shown below) were diluted
to each concentration with serum-free medium, and the
cells were incubated with them for 48 h at 37°C. After
the cells had been dissociated with 0.25% trypsin solu-
tion, suspended in medium, and mixed with 0.5% Try-
pan blue reagent (Wako Pure Chemical Industries,
Osaka, Japan; 1:1), the total number of cells was counted
using Thoma’s hemocytometer. All assays were per-
formed in triplicate. All values are presented as the
mean ± SD.
Activin A, activin AB, and follistatin, which were puri-
fied by Y.H. [32], were used for cell proliferation analysis
btDYZ
345bp
brDNA
341bp
M4 0 1 39 8 7 6 5 2M 1
Figure 1 Characteristics of fibroblastic cells (C cell) derived
from trophoblastic tissue with male fetus. Lane 1: stromal cells
derived from mother endometrium, Lane 2: epithelial cells derived
from mother epithelium, Lane 3: dermal cells from mother skin,
Lane 4: stromal cells from trophoblastic tissue: Lane 5: stromal cells
from fetus, Lane 6-10: fibroblastic cells (C cell) from trophoblastic
tissue which has male fetus. These cells were established from
different conceptus, respectively. btDYZ was amplified with RT-PCR
using following male specific gene primers [28]. btDYZ, Forward:
CCTTTAGGGGAAAATGGACTGACA, Reverse:
ATGTGACACTGCTGGAAGG. brDNA (bovine ribosomal DNA, Control),
Forward: CCAGTGCTCTGAATGTCAAA, Reverse:
GCCTCCCAGTTATTCTACAC.
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chased from commercial companies: FGF2 (0.1~100 ng/
mL, WAKO 067-02831), HB-EGF (0.1~100 ng/mL,
WAKO 084-08281), and TGFb1 (0.01~10 ng/mL,
WAKO 204-14291) were from Wako chemical co.
Microarray analysis
A customized bovine oligonucleotide microarray with
11,000 unique genes (GPL9136) was used to detect the
genes expressed in the fetal membrane and endometrial
tissues in the gravid and non-gravid uterine horn. The
oligo-microarray produced by Agilent Technologies
(Santa Clara, CA, USA) was used in this study. Sixty-mer
nucleotide probes for the customized microarray were
synthesized on a glass slide. The annotated bovine oligo-
nucleotide array represented 10263 sequences, 4466 of
which were known bovine genes, 5697 were unknown
sequences and possible candidates for novel bovine
genes, and 100 were internal references. All total RNA
and mRNA tested including those examined by RT-PCR
had their quality and quantity confirmed using either a
Bioanalyzer (Agilent) or Nanodrop (Nanodrop Co.). We
performed one-color microarray analysis, and fluores-
cence-labelled (Cy3) cRNA probes were prepared from
400 ng of total RNA of each sample using a Low RNA
Input Linear Amplification Kit (Agilent Technologies).
Labeled cRNA probes (600 ng each) were then hybridized
and washed using the Gene Expression Hybridization Kit
and Gene Expression Wash Pack Kit (Agilent Technolo-
gies), according to the manufacturer’s instructions. After
being washed, the arrays were scanned using an Agilent
Microarray Scanner (Agilent Technologies), and Feature
Extraction ver. 9.1 (Agilent Technologies) was used for
image analysis and data extraction. The microarray data
from each sample were imported into GeneSpring 7.3
(Agilent Technologies) for further data characterization.
The GEO accession number is as GSE23981 http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23981, and
Platforms are GPL9136 and GPL10134.
Real-time RT-PCR(QPCR)
The total RNA was isolated from the fetal and endome-
trial tissues, BT-1 and SKIN cells, respectively used for
microarray or RT-PCR analysis using TRIzol Reagent
(Invitrogen, Carlsbad, CA, USA), according to the man-
ufacturer’s instructions. After verifying the quality of the
RNA, one μg of total RNA was used for reverse tran-
scription. The total RNA was then reverse transcribed
into cDNA for 120 min at 37°C by MultiScribeTM
reverse transcriptase (Perkin-Elmer Applied Biosystems,
Foster City, CA) with a random primer dNTP mixture,
MgCl2, and an RNase inhibitor.
The gene expression levels of fibroblast growth factor
2 (FGF2), follistatin (FST), heparin-binding epidermal
growth factor-like growth factor (HBEGF), inhibin alpha
(INHA), activin beta A (INHbA), activin beta B
(INHbB), and transforming growth factor beta 1
(TGFb1) were quantitatively confirmed by real-time RT-
PCR analysis (QPCR) using the SYBR Green assay. Pri-
mer pairs were designed using the Primer Express 3.0
software program (Applied Biosystems) and are listed in
Table 2. The thermal cycling conditions included the
initial incubation of the samples at 50°C for two minutes
and 95°C for ten minutes, followed by forty cycles of 95°
C for fifteen seconds and 60°C for one minute. The
cycle-threshold values (CT) indicate the quantity of the
target gene in each sample. The relative difference in
the initial amount of each mRNA species (or cDNA)
was determined by comparing the CT values. The stan-
dard curves for each gene were generated by serially
diluting plasmids containing FGF2, FST, HBEGF, INHA,
INHbA, INHbB, TGFb1, or GAPDH cDNA to quantify
the mRNA concentrations produced. The expression
ratio of each gene to GAPDH mRNA was calculated to
adjust for any variation in the RT-PCR reaction. All
values are presented as the mean ± SD. The expression
of the inhibin bA gene during gestation was examined
by another QPCR procedure. Briefly, one microgram of
total RNA was reverse transcribed into cDNA in a total
volume of 20 μL. QPCR was performed using SYBR
Green fluorescence (Applied Biosystems, Foster City,
CA, USA) to quantify inhibin bA gene expression.
Bovine glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as endogenous reference gene. The
reaction mixture contained the cDNA template (1 μL),
0.4 μM each primer, SYBR Green PCR master mix
(Applied Biosystems), and nuclease free water. The ther-
mal cycling conditions included 2 min at 50 C and 10
min at 95 C. Thermal cycling proceeded with 40 cycles
Table 2 Sequences of the oligonucleotide primers used
for real-time RT-PCR
Gene name Strand Sequence
FGF2 Forward 5’-CCAGTTGGTATGTGGCACTGA-3’
Reverse 5’-GGTCCTGTTTTGGGTCCAAGT-3’
FST Forward 5’-GCGTGCTGCTGGAAGTGAA-3’
Reverse 5’-CGGTGTCTTCCGAAATGGA-3’
HBEGF Forward 5’-AGCTCCGGGTTCCAACCT-3’
Reverse 5’-ATGGCACCTCTCTCCGTGAT-3’
INHA Forward 5’-AGGAGGGCCTCTTCACGTATG-3’
Reverse 5’-TCCAGTCCTGTGTGGAACCA-3’
INHbA Forward 5’-GGCCACCCTCCCAAAGG-3’
Reverse 5’-TTAACGGCCTCCACCATCTC-3’
INHbB Forward 5’-CCGGGTCCGCCTGTACTT-3’
Reverse 5’-GCCTGCACCACAAACAGGTT-3’
TGFb1 Forward 5’-TGAGCCAGAGGCGGACTACT-3’
Reverse 5’-TGCCGTATTCCACCATTAGCA-3’
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were designed using the primer express software version
1.0, according to the manufacturer’s instructions
(Applied Biosystems). The primer sequences are given
below together with their respective GenBank accession
numbers within brackets. GAPDH (U85042): forward,
5’-aaggccatcaccatcttcca-3’; reverse, 5’-ccactacatactcagcac-
cagcat-3’. The primers were commercially synthesized
(Espec Oligo Service, Japan), and QPCR detection was
performed using an ABI PRISM 7700 sequence detector
and SDS software version 1.7.
Western blot analysis
To analyze activin-like protein expression, BT-1 cell
extracts (100 μg) and supernatants (200 μL) were
applied to Western blotting, as described previously
with some modifications [29]. In brief, these proteins
were added to sample buffer and boiled for 3 min,
before being applied to an SDS polyacrylamide slab gel
according to the method of Laemmli [33] using a Mini
Protean III apparatus (Millipore corporation, BioRad,
MA, USA). The proteins were electroblotted onto a
polyvinylidene difluoride membrane (Immobilon-P,
Millipore) using transblot apparatus (transblot SD cell,
BioRad). After being blocked with 5% ECL blocking
agent (GE Healthcare, NJ, USA), the membrane was
incubated with anti-activin bA diluted 1000-fold over-
night at 4°C, followed by incubation with alkaline phos-
phatase-conjugated antibody (Sigma) for 1 h at room
temperature. For the absorption experiment, 1 μg of pri-
mary antibody was incubated with 8 μg of purified acti-
vin A for 1 hr, before they were incubated with the
membrane. Anti-activin bA antibody and purified activin
A were prepared by Dr Hasegawa of Kitasato University
[34]. Immunopositive bands were visualized using an
Alkaline Phosphatase Conjugate Substrate Kit (BioRad).
Statistical Analysis
The cell proliferation and QPCR data were analyzed by
JMP software (SAS Institute Inc, Cary NC, USA) with
o n ew a yA N O V Af o l l o w e db yt h eD u n n e t t ’s multiple
comparison test. P-value of < 0.05 was considered
significant.
Results
Gene expression levels of TGFb super-family members in
the fetal membrane and endometrium during
implantation
Around Day 35 of gestation, no placentomal villi (chor-
ionic villi), which were identified as spots with fine
capillaries, were found in the FM in the NGH, and less
than 30 villi were macromorphologically confirmed in
the FM in the GH (data not shown). Microarray analysis
showed that the expression levels of various trophoblast
specific genes were higher in the END of the GH than
those in the END of the NGH; namely CSH1,P R P ,
PAG, AIF, and Muc-1. In FM, activin-related genes like
INHA, INHbA,I NHbB, FST, TGFb1,a n dHB-EGF were
detectable in both the GH and the NGH; however,
FGF2 was not detectable (Tables 3, 4). These data were
confirmed by QPCR (Figure 2). There were no signifi-
cant differences in the expression levels of these genes
between the FM in the GH and NGH. No difference
w a ss e e ni nt h ee n d o m e t r i a lINHA and FST expression
levels between the GH and NGH, and quite high expres-
sion levels were detected during the estrous cycle com-
pared to those observed during gestation although the
difference was not significant. INbA expression in the
GH.END was much higher than those in other tissues
(over 0.2 vs. less than 0.05). In the GH, the expression
levels of INHbA, INHbB, FGF2,a n dIGF1 in the END
were significantly higher than those in the FM (p <
0.05).
When INHbA expression throughout gestation was
analyzed by QPCR, higher expression levels were
detected in the COT during early gestation and in the
ICOT during the middle period of gestation. Similar
Table 3 Gene expression in the fetal membrane on Day
35 of gestation
Gene Gravid
(n = 3)
Non-gravid
(n = 2)
Ratio Gravid/
Non-gravid
EGF 0.03 ± 0.03
a 0.01 2.52
EGFR 1.68 ± 0.66 1.57 1.07
FGF2 0.01 ± 0.00 0.01 0.76
FST 84.74 ± 77.11 85.60 0.99
IGF1 0.02 ± 0.02 0.01 0.35
INHA 6.95 ± 2.37 6.10 1.14
INHBA 3.29 ± 2.84 248.39 0.01
INHBB 0.03 ± 0.03 0.15 0.19
TGFB1 1.41 ± 0.55 1.54 0.91
BMP3b 0.02 0.03 0.6
BMP4 1.41 ± 0.76 2.08 0.7
BMP15 0.01 ± 0.00 0.02 0.5
ACVR1 0.84 ± 0.13 1.02 0.8
ACVR2 0.90 ± 0.01 0.87 1.0
ACVR2B 0.48 ± 0.04 0.61 0.8
TGFBR1 1.02 ± 0.75 0.24 4.3
BMPR1A 0.10 ± 0.01 0.17 0.6
BMPR1B 0.04 ± 0.03 0.20 0.2
BMPR2 0.33 ± 0.13 0.37 0.9
SMAD2 7.30 ± 0.90 8.05 0.9
CSH1 184.28 ± 16.47 2.71 68.0
PAG1 72.83 ± 15.22 0.59 124.0
PRP1 13.55 ± 4.70 0.37 37.0
IFNT 0.04 ± 0.05 0.24 0.2
aMean ± SD.
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ICAR. However, two to three times higher expression
intensities were detected in area from the END to the
FM (Figures 3, 4).
Expression of TGFb super-family members in BT-1 cells
BT-1 cells possess some trophoblastic cell features
derived from in vitro fertilized ova [30], so we used them
as a representative source replacing in vivo trophoblastic
cells from the extra-embryonic membrane. First, the
expression of various growth factors/cytokines was exam-
ined by QPCR. As a result, BT-1 cells were found to
express FGF2, HBEGF, INHbA, INHbB, FST, and TGFb1,
all of which were also detected in SKIN cells, which were
used as the control (general somatic cells) (Figure 5).
There were significant differences between the expression
levels of these molecules in BT-1 and SKIN cells (except
for in INHA expression) (P < 0.05).
Effects of trophoblast extracts on cell proliferation
To examine whether trophoblastic factors stimulate
endometrial cell proliferation, extracts containing 1-100
μg/mL proteins from the fetal membrane, BT-1, and
SKIN cells were applied to in vitro cell cultures of two
cell lines with different origins, E as bovine endometrial
fibroblast cells and C as bovine cotyledonary fibroblast
cells. The trophoblast and BT-1 extracts stimulated cell
proliferation in both E and C cells (Figure 6a and 6b,
respectively); however, the SKIN cell extract had no
effect. Cell proliferation analysis using C cells showed
that the extracts from trophoblasts and BT-1 cells
enhanced cell growth.
Activin protein expression in trophoblast cells
We next examined whether activin protein is expressed
in trophoblastic cells using BT-1 cells as a model.
Although activin-bA protein was found in BT-1 extract
and culture supernatant by Western blot analysis, only
small amounts of the appropriate sized proteins were
detected in BT-1 cells and culture media (Figure 7). The
activin-bA subunit was found in BT-1 culture superna-
tant as a 13 kDa protein but many nonspecific bands
including a 26 kDa protein were also found in the
extract (Figure 7a). The excess application of semi-
purified activin to anti-activin sera showed the simulta-
neous disappearance of both the 13 and 26 kDa proteins
in BT-1 cells.
Table 4 Gene expression in the endometrium on Day 35
of gestation
Gene Gravid
(n = 3)
Non-gravid
(n = 3)
Ratio Gravid/
Non-gravid
EGF 0.60 ± 0.95
a 0.06 ± 0.04 10.58
EGFR 0.60 ± 0.35 0.78 ± 0.41 0.76
FGF2 0.05 ± 0.07 0.13 ± 0.01 0.39
FST 21.57 ± 10.07 11.35 ± 6.47 1.90
IGF1 0.07 ± 0.09 0.17 ± 0.20 0.40
INHA 0.96 ± 0.32 1.01 ± 0.48 0.96
INHBA 536.20 ± 314.75 31.78 ± 40.56 16.87
INHBB 0.14 ± 0.11 0.03 ± 0.01 5.55
TGFB1 0.51 ± 0.31 0.76 ± 0.26 0.67
BMP3b 0.01 0.01 1.0
BMP4 0.98 ± 0.49 0.87 ± 0.34 1.1
BMP15 0.15 ± 0.24 0.08 ± 0.11 2.0
ACVR1 0.83 ± 0.28 1.02 ± 0.14 0.8
ACVR2 0.13 ± 0.10 0.15 ± 0.01 0.8
ACVR2B 0.31 ± 0.16 0.42 ± 0.20 0.7
TGFBR1 0.13 ± 0.10 0.08 ± 0.07 1.6
BMPR1A 0.08 ± 0.07 0.32 ± 0.14 0.3
BMPR1B 0.01 ± 0.00 0.01 ± 0.00 1.0
BMPR2 0.29 ± 0.15 0.27 ± 0.09 1.1
SMAD2 4.93 ± 1.98 4.34 ± 0.65 1.1
aMean ± SD.
Figure 2 Expression of activin and related genes in the fetal
membrane on Day 35 of gestation. The expression levels of
FGF2, FST, HBEGF, INHA, INHBA, INHBB, and TGFB1 mRNA in gravid
and non gravid horn tissues (FM.GH, FM.NGH, END.GH, and END.
NGH) were detected by QRT-PCR. The expression of these genes
was normalized to the expression of GAPDH measured in the same
RNA preparation. The values are shown as the mean ± SD. FM.GH:
gravid horn fetal membrane, FM.NGH: non-gravid horn fetal
membrane, END.GH: gravid horn endometrium, END.NGH: non-
gravid horn endometrium. END.Cyclic: endometrium in the luteal
phase during the estrous cycle (day 7-14).
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Page 6 of 12Cell proliferative activity of growth factors
To confirm whether activin displays proliferative activity
in the endometrium, we applied various growth factors
including activin-A and -AB to E and C fibroblast cell
preparations. Although activin-A and -AB, FGF2, in and
TGFb stimulated the proliferation of both cell lines, fol-
listatin had no effect on either cell type. HB-EGF stimu-
lated E cell growth (Figure 8).
Discussion
Implantation is a complex process involving various fac-
tors and biochemical and molecular modifications: cell-
to-cell contact between cells with different origins, cell
invasion and/or fusion depending on species, endome-
trial cell proliferation, and matrix reorganization. In the
ruminant endometrium, feto-maternal events mainly
occur in a limited area named the caruncle [1,35].
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Figure 3 Activin bA mRNA expression in cotyledonary (a, COT) and intercotyledonary (b, ICOT) tissues throughout gestation.G e n e
expression was detected by QPCR.
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Figure 4 Activin bA mRNA expression in caruncular (a, CAR) and intercaruncular (b, ICAR) tissues throughout gestation.G e n e
expression was detected by QPCR.
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Page 7 of 12However, how and why cell-cell contact and active cell
proliferation are initiated in the caruncle in ruminants
rather than in the intercaruncle remain answered. Dur-
ing implantation, the embryo is stimulated by maternal
factors, uterine milk protein and serpin [36,37], which
ensure a suitable environment for fetal development. At
the same time, endometrial functions, and especially
those in the caruncle in bovines, are regulated by fetal-
side factors, for example interferon-tau, which stimu-
lates endometrial prostaglandins and the ovarian corpus
luteum, which functions as a factor for the recognition
of gestation [38-42]. In the present study, we explored
Figure 5 Expression of activin and related genes in trophoblastic cells (BT-1). Gene expression was detected by QPCR in BT-1 and SKIN
cells. The expression of these genes is shown as copy number per 20 ng total RNA. The values are shown as mean ± SD. BT-1: a trophoblastic
cell line established by Shimada et al. (2001), SKIN: cells derived from bovine skin as a control.
Figure 6 Effects of trophoblastic tissue extracts on the proliferation of fibroblast cells. EM: trophoblast tissue extracts with protein
concentrations ranging from 1~100 μg/mL, BT-1: cell extracts with the same protein concentrations as the EM, SKIN: cell extracts from the skin.
These extracts were applied to endometrial fibroblast cells (E) and cotyledonary fibroblast cells (C). The values (mean ± SD) are expressed as
percentages relative to the value obtained for the relevant untreated group (control). Dunnett’s multiple comparison test was carried out to test
the differences between the control and the treatment groups: *P < 0.05, **P < 0.01.
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super-family, at the feto-maternal interface. As in other
species such as humans and mice, activin plays a crucial
role in endometrial remodelling, but there is little infor-
mation regarding the role of the TGFb super-family in
ruminants [15,43]. Although the structure of the bovine
placenta is different from those of humans and mice;
namely, the former is a non-invasive placenta but the
latter is an invasive placenta, endometrial remodelling is
still necessary for placentogenesis in bovines [44]. Dis-
cordant feto-maternal organization causes embryo loss.
The caruncular and intercaruncular area play different
roles in the bovine endometrium, and their gene expres-
sion patterns have been identified [45,46]
Extracts from the extra-embryonic membrane stimu-
lated cell proliferation in an in vitro fibroblast cell cul-
ture, and BT-1 cells, which are derived from bovine
blastocysts and have trophoblastic features, also stimu-
lated cell proliferation effectively (Figure 4). These data
suggest that trophoblastic cells contain a factor that sti-
mulates bovine endometrial cell proliferation in the car-
uncle. Although trophoblast tissue expresses many
factors including vascular factors (VEGF and their
receptors, TGF, IGF, PIGF, etc. [47]), the most impor-
tant factor remains unknown. Microarray and QPCR
confirmed that various molecules including FGF2,
INHbA, INHbB, FST, HBEGF,a n dTGFb. were detect-
able in the END; however, most of them were highly
expressed in the END.GH. A comparison between the
gene expression patterns in gravid and non-gravid horn
trophoblasts showed that in the fetal membrane specific
molecules such as placental lactogen (PL), prolactin-
related protein (PRP), and pregnancy-associated glyco-
protein (PAG) were expressed more in gravid horn
trophoblasts. These results agreed with those of a
previous report [8] and imply that members of the TGFb
super-family including activin play roles in endometrial
receptivity in ruminants. As in the gravid horn, the fusion
of trophoblast cells and the endometrial epithelium starts
earlier than in the non-gravid horn; namely, it may be
evidence of the initiation of implantation [8,43].
Activin was detected in bovine blastocysts as well as in
human and mouse blastocysts [11,13,48,49]. It stimulates
the development of the embryo; i.e., cell proliferation of
the blastocyst and attachment in humans and mice
[48,50,51]. Placental villi produce activin A and promote
hormone production, and these hormones direct the
formation of the trophoblastic syncytium [52]. Although
endometrial activin production is known to occur in
these species [26], there is no information regarding its
function in the bovine caruncular endometrium. TGFb
super-family genes including activin genes (INHbA and
INHbB) may play crucial roles in the proliferation of
various cell types such as endometrial, immune, stem,
ovarian and tumor cells [53-55]. In the present study,
high INHbA expression was found in the gravid endo-
metrium, and our findings suggest that activin plays a
similar role as a regulator of endometrial remodelling in
humans even though bovine endometrial cells are not
involved in decidualization during implantation [17,52].
Endometrial remodelling is necessary for bovine implan-
tation [56,57], and a comparison between gravid and
non-gravid endometrial molecular expression implied
that the initiation of implantation and cell proliferation
in the bovine caruncular endometrium is regulated by
fetal-side trophoblasts. However, there are no reports
regarding fetal-side stimulation. We hypothesized that
trophoblastic factors participate in rapid spatiotemporal
endometrial cell proliferation during bovine implanta-
tion. Using BT-1 cells, which possess trophoblastic fea-
tures, we attempted to identify activin and detected
various molecules immunologically (Figure 5). Extracts
from fetal trophoblastic tissues and BT-1 cells stimu-
lated cell proliferation. These findings suggest that fetal-
side tissues stimulate endometrial remodelling and
development during implantation. Activin activity is
regulated by various factors including FST, and FST
expression is higher than that of activin genes in bovine
trophoblastic tissues [20,55]. Therefore, activin may not
be active in fetal trophoblasts at this time. Although
activin is not the only factor that stimulates cell prolif-
eration in the bovine endometrium, it may play an
important role in endometrial remodelling and develop-
ment [52]. The detailed roles of activin in bovine
Figure 7 Immunological activin bA analysis in trophoblast cells
(BT-1). (a) Activin protein was detected by Western blotting using
anti-activin bA sera. Lane 1: purified activin as a positive control,
lane 2: culture medium of BT-1 cells, lane 3: BT-1 cell extract. (b)
Activin protein was detected using anti-activin bA sera, which was
absorbed with an excess of purified activin bA protein (Lane 3, 4).
Lanes 1 and 3: purified activin A, lanes 2 and 4: BT-1 extracts.
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Page 9 of 12endometrial remodelling and implantation require
further study.
In the present study, other molecules were found to
be expressed in the fetal and endometrial tissues, (FGF2,
HB-EGF, and TGFb1), but their biological roles are still
obscure. Almost no expression of FGF2 was detected in
the trophoblastic tissues but it did demonstrate prolif-
erative activity in cell culture. Endometrial FGF2 may be
important for endometrial remodelling and implantation
and may be related to interferon tau expression [58,59].
In addition, HB-EGF may play a specific role during
implantation on both the maternal and fetal sides
[12,60,61]; however, this requires further study.
Conclusions
TGFb super-family genes are specifically expressed in the
bovine endometrial and trophoblastic tissues in a specific
spacio-temporal manner. INHbA (activin bA) was found
to be highly expressed in the gravid horn endometrium,
but its expression was low in trophoblasts. Several factors
Figure 8 Cell proliferation analysis of activin and related growth factors. Purified activin A, activin AB, and follistatin were applied to E and
C cells at concentrations ranging from 1 to 1000 ng/mL. FGF2 and HB-EGF were used at concentrations ranging from 0.1 to 100 ng/mL. TGFb1
was used at concentrations ranging from 0.01 to 10 ng/mL. The values (mean ± SD) are expressed as percentages relative to the value obtained
for the relevant untreated group (control). Dunnett’s multiple comparison test was carried out to test the differences between the control and
treatment groups: *P < 0.05, **P < 0.01.
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Page 10 of 12derived from trophoblastic tissues stimulated the prolif-
eration of fibroblast cells, and activin may participate in
endometrial proliferation. These results suggest that
TGFb super-family members including activin, which are
produced by trophoblasts and the endometrium, play a
crucial role in endometrial remodeling during the peri-
implantation period in cattle. In addition, bovine tropho-
blastic tissues contain various other cytokine/growth fac-
tors that may be important for placental growth during
bovine placentation.
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